🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Immediate Implant Placement With Autogenous Maxillary Tuberosity Graft in the Esthetic Zone

RecruitingNAAges 18 Years - anyAllUniversity of Medicine and Pharmacy at Ho Chi Min…
NCT07460076 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Immediate implant placement in the esthetic zone is often associated with buccal bone deficiency, which may compromise esthetic outcomes and long-term implant stability. Autogenous bone graft harvested from the maxillary tuberosity provides corticocancellous bone with favorable biological properties and may help reconstruct the buccal bone plate during immediate implant placement. This prospective case series aims to evaluate the clinical and esthetic outcomes of immediate implant placement combined with autogenous maxillary tuberosity graft in the esthetic zone. The primary outcomes include buccal bone thickness measured on cone-beam computed tomography (CBCT), facial soft tissue thickness measured clinically, and the pink esthetic score (PES) after implant restoration.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older * Patients requiring single implant placement in the maxillary esthetic zone * Indication for immediate implant placement following tooth extraction * Presence of a buccal bone defect requiring augmentation with an autogenous maxillary tuberosity bone graft * Adequate oral hygiene and ability to maintain postoperative care * Willingness to participate in the study and provide informed consent Exclusion Criteria: * Uncontrolled sHistory of radiotherapy in the head and neck region ystemic diseases * History of radiotherapy in the head and neck region * Active periodontal disease or untreated oral infection * Heavy smoking (more than 10 cigarettes per day) * Pregnancy or lactation * Severe parafunctional habits * Insufficient bone volume preventing implant placement with the planned protocol * Patients unable to attend follow-up visits
💊

What it tests

  • Immediate Implant Placement With Maxillary Tuberosity Autogenous Graft
📍

Where

1 site
University of Medicine and Pharmacy at Ho Chi Minh City
Ho Chi Minh City, Vietnam
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy